TP53 and neoplasm: Upper and lower GI tumours had a large proportion of negative SSTR-2a (upper GI: 76%; lower GI: 61%), negative CgA (upper GI: 40%; lower GI: 48%), and strongly positive p53-staining (upper GI: 50%; lower GI: 56%).